Company Introduction
Our Plant is WHO-cGMP Certified; state level GMP & GLP certified for the manufacture of a wide range of: Oncology products (Liquid and Lyophilized Injection, Tablets and Capsules) & General Injectables (Liquid & Lyophilized Injection and Pre filled syringes). Biozenta is working towards spearheading their presence globally.Our Facility has accreditation from regulatory bodies of: Kenya; Yemen, Iran PICS, Cambodia, Philippines & Malawi and awaiting site registration in Srilanka, Peru, Ethiopia, Syria, Tanzania, Nepal, and Iran.
Our dedicated regulatory team has filed for dossier registration in Myanmar, Costarica, Guatemala, Bolivia, Uzbekistan, Mongolia, Mexico, Ethiopia, Cuba, Nepal, Ecuador, Honduras, Vietnam, Tanzania, Kenya, and Algeria.
Milestone
2018 First Milestone - Biozenta registered its company in Roorkee, Uttarakhand.
2019 Second Milestone - Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.
2021 Third Milestone - Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.
2021 Fourth Milestone - Established, "Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.
2021 Fifth Milestone - Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.
2021 Sixth Milestone - Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.
2023 Seventh Milestone - Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.
2023 Eighth Milestone - Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.
2023 Ninth Milestone - Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.
2023 Tenth Milestone - "Launching into the Domestic Marketing Division" at Mohali, 2023.
2023 Eleventh Milestone - Inaugurated its new “Corporate office” as “Biozenta, USA”